⭐ UPDATE: My Mum’s Astron Health Results Are In — And This Confirms Everything We’ve Been Building

Hey Warriors 🙂, I’ve been a bit quieter lately as we’ve been working behind the scenes on something important:

My mum completed the Astron Health multi-omic analysis, and the results have finally arrived.

Next week we meet Astron’s integrative oncologist to go through the full interpretation — but I want to share the key insights now, because this is something that can empower every person in this community.

⭐ What Astron Revealed About My Mum’s Cancer

Her tumour is not random.

It runs on specific biological pathways — almost like an engine with identifiable components.

The major drivers they identified were:

🔥 FGFR2 → MAPK (Main Growth Engine)

🔥 VEGF / Angiogenesis (Blood Supply)

🔥 MMP15 (Invasion + Tissue Breakdown)

🔥 WNT Signalling (Stem-Cell Survival + Recurrence)

🔥 FANCA Mutation (DNA-Repair Weakness → ROS Sensitivity)

And important update:

➡️ CTCs were only 2, which is very low and extremely reassuring.

⭐ This Report Was NOT Essential — But It Was Incredibly Helpful

I want to make something clear to everyone:

You do NOT need expensive molecular testing to build an effective, multi-pathway protocol.

Over the past 1.5 years, I created my mum’s protocol by studying:

cancer signalling pathways
metabolic vulnerabilities
invasion markers
angiogenesis mechanisms
mitochondrial weaknesses
stem-cell biology

And what shocked me was this:

The Astron findings matched almost exactly what I had already built through research alone.

This is HUGE for this community.

It proves that:

✔ you can learn what drives your cancer

✔ you can build precision strategies without testing

✔ you can target the actual pathways behind the disease

✔ you do NOT need to shoot in the dark

The report confirmed the work — it didn’t create it.

⭐ The One Pathway We Had Not Fully Targeted: RAS → MAPK

Astron’s report highlighted one important component:

Atorvastatin

This inhibits RAS prenylation, which is the top upstream switch that activates the MAPK pathway — the main engine of her tumour.

We were already suppressing MAPK downstream with Curcumin, EGCG, Resveratrol, Melatonin etc,

but Atorvastatin blocks the pathway at its origin.

So this was the only missing piece.

⭐ The Report Also Validated Two Compounds I HAD Already Included

These two were not “new” — they were already in my mum’s protocol — but Astron confirmed why they’re biologically important for her case:

1️⃣ Doxycycline — Direct MMP15 Inhibitor (Her Big Invasion Driver)

Her tumour showed a massive overexpression of MMP15, which is involved in:

tissue invasion
inflammation
local irritation
potential spread
breakdown of extracellular matrix

Curcumin, EGCG, and Resveratrol all help…

but Doxycycline is the strongest inhibitor of MMP activity, including MMP15.

So this was already correctly placed in her protocol — and Astron’s report validated it.

2️⃣ Niclosamide — WNT Shutdown (Her Stem-Cell Survival Pathway)

Astron showed upregulation of WNT10A and FZD3.

This means the tumour is using WNT signalling to:

stay alive long-term
resist therapy
preserve cancer stem-cell populations

Niclosamide is one of the strongest WNT/β-catenin inhibitors,

and I had already included it months ago based on her clinical behaviour.

Again — Astron’s report confirmed this was the right call.

⭐ Why I’m Sharing All This

This community was built on education, empowerment, and precision — not blind protocols.

And here’s the message I want you all to hear:

✔ Testing like Astron can accelerate understanding.

✔ But it is NOT required to fight cancer intelligently.

✔ You can learn your cancer’s biology through research.

✔ You can identify pathways through symptoms and behaviour.

✔ You can build a pathway-based strategy without waiting for testing.

The report helped — massively.

But the strategy we built over the last 18 months was already hitting almost every critical pathway as shown by her low CTCs.

That should inspire you.

⭐ What’s Next

Meeting with Astron’s integrative oncologist next week
Refining the pathway-targeting plan even further
Sharing the insights with this community
Continuing to teach pathway-based thinking so you can apply it to your own case

And I’ll also be posting below the Podcast Episode with Astron Health, Jane McLelland, and Dan Atkinson, which will help you understand this even deeper.

⭐ Final Message

No one should be fighting cancer with guesswork.

Understanding your biology gives you power.

And whether you get a molecular test or not,

you CAN learn what drives your cancer

and you CAN target it with precision.

Our community stands for exactly that.

Much love to all of you,

More updates coming soon.

PS — A Powerful Reminder About the Mind

A dear friend in this group, who has GBM, shared something with me recently:

her tumour has started shrinking.